Seres Therapeutics (MCRB) Other Gross PP&E Adjustments (2016 - 2026)
Seres Therapeutics (MCRB) has disclosed Other Gross PP&E Adjustments for 11 consecutive years, with -$36.8 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments rose 18.14% to -$36.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$36.8 million through Dec 2025, up 18.14% year-over-year, with the annual reading at -$36.8 million for FY2025, 18.14% up from the prior year.
- Other Gross PP&E Adjustments hit -$36.8 million in Q4 2025 for Seres Therapeutics, down from -$9.7 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $44.5 million in Q3 2021 to a low of -$63.0 million in Q4 2022.
- Historically, Other Gross PP&E Adjustments has averaged -$8.1 million across 5 years, with a median of -$16.1 million in 2024.
- Biggest five-year swings in Other Gross PP&E Adjustments: tumbled 363.04% in 2022 and later skyrocketed 62.61% in 2025.
- Year by year, Other Gross PP&E Adjustments stood at $24.0 million in 2021, then crashed by 363.04% to -$63.0 million in 2022, then rose by 21.24% to -$49.6 million in 2023, then rose by 9.33% to -$45.0 million in 2024, then rose by 18.14% to -$36.8 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for MCRB at -$36.8 million in Q4 2025, -$9.7 million in Q3 2025, and -$11.8 million in Q2 2025.